Home
/
Trulieve Cannabis Corp.
/
Financials
/
Quarterly
Trulieve Cannabis Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Trulieve Cannabis Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$288.19M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$302.09M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$297.76M
May 7, 2025
Q3
2025
Sep 30, 2024
$284.28M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$303.44M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$297.62M
May 7, 2025
Q3
2024
Sep 30, 2023
$275.21M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$281.80M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$285.21M
May 9, 2024
Q3
2023
Sep 30, 2022
$295.35M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$313.84M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$317.75M
May 10, 2023
Q3
2022
Sep 30, 2021
$224.09M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$215.12M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$193.82M
May 12, 2022
Q3
2021
Sep 30, 2020
$136.27M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$120.77M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$96.06M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($61.60M)
Nov 5, 2024
Q2
2024
Jun 30, 2024
($11.98M)
Aug 6, 2024
Q1
2024
Mar 31, 2024
($24.52M)
May 9, 2024
Q3
2024
Sep 30, 2023
($25.84M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($406.87M)
Aug 6, 2024
Q3
2023
Jun 30, 2023
($406.87M)
Nov 9, 2023
Q2
2023
Mar 31, 2023
($65.63M)
Aug 9, 2023
Q1
2024
Mar 31, 2023
($67.14M)
May 9, 2024
Q3
2023
Mar 31, 2023
($65.63M)
Nov 9, 2023
Q3
2023
Sep 30, 2022
($115.07M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($24.02M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($24.02M)
Aug 9, 2023
Q2
2023
Mar 31, 2022
($32.48M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($32.48M)
May 10, 2023
Q3
2023
Mar 31, 2022
($32.48M)
Nov 9, 2023
Q3
2022
Sep 30, 2021
$18.62M
Nov 9, 2022
Q3
2022
Jun 30, 2021
$40.88M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$40.88M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$30.08M
May 12, 2022
Q2
2022
Mar 31, 2021
$30.08M
Aug 10, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$42.24M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$52.63M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$33.33M
May 7, 2025
Q3
2025
Sep 30, 2024
$618.0K
Nov 5, 2025
Q2
2025
Jun 30, 2024
$49.75M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$46.10M
May 7, 2025
Q3
2024
Sep 30, 2023
$23.34M
Nov 5, 2024
Q2
2024
Jun 30, 2023
($291.29M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
$17.15M
May 9, 2024
Q3
2023
Sep 30, 2022
($27.34M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
$41.47M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$29.17M
May 10, 2023
Q3
2022
Sep 30, 2021
$66.28M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$76.30M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$72.56M
May 12, 2022
Q3
2021
Sep 30, 2020
$59.47M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$52.48M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$42.51M
May 13, 2021